Home   About this service   Get the news  
+32 2 743 34 03

 
UCB [BE0003739530 / UCB]

UCB Media Room - Transparency Notifications

INFORMATION REGLEMENTEE


[01/08/2019 | 20:01]
https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W2=
7HkUdGSImvHQ6Hnxecnthvo7TvsVqC7qtiy48J-2FLSq-2FvYs-2BOYXuee1l3e1iTkyPBqQEZC=
UuD77NZd-2BZMZKciVsQLt3gqjnIBVBkYpvS_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5B=
wmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsADu6=
Djs9N3NJqASebxl71CFCj7MZYaNICADyrVD4sS1V67eRfGmWctsLsHbRHNy-2Bku5gWZNkM7U3Q=
dmbgwV92-2BLKpYn0D7ZeDmp3kUgTRJOj3TCFMV9l4RihNGZqaLI0KdkJHIREHzA3LSiAgE7FtT=
u2Z9dMnAOrPJuLJUdjxlLCmjaFCN1sL-2BPo2ONZ61cwqxIbBdWkAKBjT6vifO3X4GXIcNz9tG-=
2BcpdtC61vHHU4W-2BO3BoMbC4zKhIKNKYOQc1g-3D

** Transparency notifications BlackRock, Inc.
------------------------------------------------------------

=C2=B7 Notifications referring to situation on 25, 26 and 29 July 2019
=C2=B7 Threshold crossed: 5%
=C2=B7 Latest holding: 4.85%

Brussels (Belgium), 1 August 2019 =E2=80=93 20:00 (CEST) =E2=80=93 regulate=
d information

1.=C2=A0 Summary of the notifications

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large =
shareholdings, UCB=C2=A0SA/NV announces that it has received 3 transparency=
notifications from BlackRock, Inc. (having its registered office at 55 Eas=
t 52nd Street, New York, NY, 10055, U.S.A.), dated 26, 29 and 30 July 2019 =
respectively.

In the first notification, BlackRock, Inc., has notified that, following a =
disposal of UCB=C2=A0shares with voting rights and a disposal of equivalent=
financial instruments by its affiliates, its total holding in UCB SA/NV ha=
s decreased and has crossed downwards the 5% threshold on 25 July 2019.

On 25 July 2019, BlackRock, Inc. (taking into account the holding of its af=
filiates) Inc. owned 9 215 306 UCB=C2=A0shares with voting rights (versus 9=
320 710 shares in its previous notification), representing 4.74% of the to=
tal number of shares issued by the company (194 505 658) (versus 4.79% in i=
ts previous notification), as well as 431 570 equivalent financial instrume=
nts (versus 433 129 in its previous notification) representing 0.22% of the=
total number of shares issued by the company (same % as in its previous no=
tification).

In the second notification, BlackRock, Inc., has notified that, following a=
n acquisition of UCB=C2=A0shares with voting rights and a disposal of equiv=
alent financial instruments by its affiliates, its total holding in UCB SA/=
NV has increased and has crossed the 5% threshold on 26 July 2019.

On 26 July 2019, BlackRock, Inc. (taking into account the holding of its af=
filiates) 9 617 448 UCB=C2=A0shares with voting rights, representing 4.94% =
of the total number of shares issued by the company, as well as 180 549 equ=
ivalent financial instruments, representing 0.09% of the total number of sh=
ares issued by the company.

In the third notification, BlackRock, Inc., has notified that, following a =
disposal of UCB=C2=A0shares with voting rights and an acquisition of equiva=
lent financial instruments by its affiliates, its total holding in UCB SA/N=
V has decreased and has crossed downwards the 5% threshold on 29 July 2019.

On 29 July 2019, BlackRock, Inc. (taking into account the holding of its af=
filiates) 9 438 644 UCB=C2=A0shares with voting rights, representing 4.85% =
of the total number of shares issued by the company, as well as 186 998 equ=
ivalent financial instruments, representing 0.10% of the total number of sh=
ares issued by the company.

2.=C2=A0 Further information

This press release and the detailed transparency notifications are availabl=
e on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://u7061=
146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RKNKE=
bAnX0k168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEbVIW=
S8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElH=
Q9EZfLoWbvi8z1TsADu6Djs9N3NJqASebxl71CFCj7MZYaNICADyrVD4sS1V67eRfGmWctsLsHb=
RHNy-2Bku5gWZNkM7U3QdmbgwV92-2BLKpYn0D7ZeDmp3kUgTRJOj780khYlegxWhrGUnWwl7IK=
1yxlGFS9kT9alI67bTQCf9GKsZjetGqb5MG0V2Zl04FbICVFMOmZ-2FxHej-2FdYpakYrNkD7mV=
9CAj2CXcRUoTwNKH3snTDBXnrkaUBT0WGGTk4EIUVdrALGGvs8ZrZkHiM-3D .

An updated overview of the UCB=C2=A0SA/NV large shareholdings will be avail=
able on UCB=C2=A0SA/NV=E2=80=99s website via the following link (https://u7=
061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQB7X3kY45D7w88RK=
NKEbAnX0k168L1blu4vXqw-2F8RdooEQ6SU3zroSdeAFOVg4KQLSg-3D-3D_-2B-2Ft0TnE1oEb=
VIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTef=
ElHQ9EZfLoWbvi8z1TsADu6Djs9N3NJqASebxl71CFCj7MZYaNICADyrVD4sS1V67eRfGmWctsL=
sHbRHNy-2Bku5gWZNkM7U3QdmbgwV92-2BLKpYn0D7ZeDmp3kUgTRJOj5Zv4L2F8JVGsBdMTCdG=
Gu0dCSn1BZVX544jbT90BjGPuGWaaUHJFZjtj3EcXfdjttsGX3AxHMC-2FxNskYFPtj52VWHI22=
Tc-2Bg4j5ogF9fh2DZIbT0rzvAuW-2BxVDUz3bI807ciC5eXzFU8fhPsgeOErs-3D .

Investor Relations

Antje Witte, Investor Relations, UCB
T +32 2 559 94 14,
antje.witte@ucb.com

Isabelle Ghellynck, Investor Relations, UCB
T +32 2 559 95 88,
isabelle.ghellynck@ucb.com

About UCB
UCB, Brussels, Belgium (www.ucb.com (https://u7061146.ct.sendgrid.net/wf/cl=
ick?upn=3D84Em28S1K9SvtzcUtu04EmJ6qK6m5fEduQTondOjhxU-3D_-2B-2Ft0TnE1oEbVIW=
S8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElH=
Q9EZfLoWbvi8z1TsADu6Djs9N3NJqASebxl71CFCj7MZYaNICADyrVD4sS1V67eRfGmWctsLsHb=
RHNy-2Bku5gWZNkM7U3QdmbgwV92-2BLKpYn0D7ZeDmp3kUgTRJOj66NVmwD2T8u1w5e-2Frivw=
Gd8Z496-2Ba5DMtBv2ydNfQCmphMgbOPF1dJ2Rcd9bnPKj-2B7Grww5XPJYUzLQMcKM9H47Ahlz=
vTvFjvhmym2QwH5Z7gP6A6M7qpPcSC2verGshDnnbxLO1NlVkveSr16V8T8-3D ) is a globa=
l biopharmaceutical company focused on the discovery and development of inn=
ovative medicines and solutions to transform the lives of people living wit=
h severe diseases of the immune system or of the central nervous system. Wi=
th 7 500 people in approximately 40 countries, the company generated revenu=
e of =E2=82=AC 4.6 billion in 2018. UCB is listed on Euronext Brussels (sym=
bol: UCB). Follow us on Twitter: @UCB_news

GenericFile
190801 - Notification de transparence comm de presse Blackrock 3TD (https:/=
/u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGS=
ImvHQ6Hnxecnthvo7TvsVqC7qtiy48J-2F77IjY8i5SYPz8an2ViUEbV4c3-2FNjrdxjHkfn6dN=
S4nI-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQ=
R0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsADu6Djs9N3NJqASebxl71CFCj7MZYaNIC=
ADyrVD4sS1V67eRfGmWctsLsHbRHNy-2Bku5gWZNkM7U3QdmbgwV92-2BLKpYn0D7ZeDmp3kUgT=
RJOj-2FSkLGVz5n3U4RbVT2EgWTVaJm3NUUdinTJlKRlQiaDbFcQfbmw05gmpLLBlgtETMJke3G=
iCxfOPnC8VUJQ2LW3hdwb8BW-2BXJ8rexzWF-2Fho4r5Tq8Szx8uGwfV5ECf8L3UDfqxQPUK0vh=
-2FCbM7GhDbk-3D GenericFile
190801 - Transparency notification press release Blackrock 3TD (https://u70=
61146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvH=
Q6Hnxecnthvo7TvsVqC7qtiy48J-2FT6LeIiTyuZvjS0S2VeAA3VyJPvsrjN0-2BUUxRW30-2FH=
Ow-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0=
hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsADu6Djs9N3NJqASebxl71CFCj7MZYaNICAD=
yrVD4sS1V67eRfGmWctsLsHbRHNy-2Bku5gWZNkM7U3QdmbgwV92-2BLKpYn0D7ZeDmp3kUgTRJ=
OjxBdVUfvbxMNEy8arznc-2BJzOeGfgvLQ-2BZ-2FyMODvsW96ViRAfzGjcgthSibVbhVXpWZk6=
JcBT7Japxe8wni6I-2Fbq2d1LLmtdlAJfXyu18nJBzgKck2zegAxYyj1yLv-2FmS5aCfxlFEWR6=
Exltz9m2Riig-3D GenericFile
190801- Transparantieverklaring persbericht BlackRock 3TD (https://u7061146=
.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQBx1W27HkUdGSImvHQ6Hnx=
ecnthvo7TvsVqC7qtiy48J-2FwrFq1aXIiGlorpCkSwVJDNHneo0f-2BjkOiTBhLN-2BH5Y8-3D=
_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZTjzwcPKItQR0hTxd9=
ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsADu6Djs9N3NJqASebxl71CFCj7MZYaNICADyrVD4=
sS1V67eRfGmWctsLsHbRHNy-2Bku5gWZNkM7U3QdmbgwV92-2BLKpYn0D7ZeDmp3kUgTRJOj26F=
v7ZYd-2FskEyP3rq6GlDit9N1iJhjB9ltJyGcHUbZtTZmUJPF5DqrbrMUngl-2B7vRgJrkvnMBE=
yfYi2ax0ji7QzNyOhzu3MRUgVLSj3xwKt-2FQexqAeSQ6QvVa8-2BNJgZrYsaeNkyAMBkH6CXXS=
oMmqQ-3D=0D
=0D
______________________=0D
If you would rather not receive future communications from UCB SA, please g=
o to https://u7061146.ct.sendgrid.net/wf/click?upn=3DG62jSYfZdO-2F12d8lSllQ=
Bz2p53T0v-2BoEIvbo6vDi8C-2BOyFzyb6obo-2BzKSgNKq4mrGVOAF6YeHO7Uc1FzgJxxJ7xUW=
jyNq-2BlKqWjM0pGCc9UYjzS2Od4YI7XgoAKZYdNp2XOBu33Ql-2BMJ2Thz5SdMHVHY-2FvC5Ae=
XHaS2Md9ksKKw-3D_-2B-2Ft0TnE1oEbVIWS8vHM8JK8eu8RpJ4re5BwmFRw6Tr0XlsWOeqQqZT=
jzwcPKItQR0hTxd9ZQ7rBLYSOuAKeTefElHQ9EZfLoWbvi8z1TsADu6Djs9N3NJqASebxl71CFC=
j7MZYaNICADyrVD4sS1V67eRfGmWctsLsHbRHNy-2Bku5gWZNkM7U3QdmbgwV92-2BLKpYn0D7Z=
eDmp3kUgTRJOj79bUNZDTbSahFV1FbqBerc-2FcSAZ2YyfqkiMWpUHLwGts-2F27ZD5LoKuPdzz=
Uaw6J-2FfRk6I0IQbk2rSU5d8EHjkla1c9AENktM3vj8zEtG6rc1v6SLej8-2F7jZuQ-2FHmmhr=
5bh8iD7WXP93maPVOlS5SUE-3D=0D
UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=